Search Results - "Gorniak, Malgorzata"
-
1
SorCS2 facilitates release of endostatin from astrocytes and controls post‐stroke angiogenesis
Published in Glia (01-06-2020)“…SorCS2 is an intracellular sorting receptor of the VPS10P domain receptor gene family recently implicated in oxidative stress response. Here, we interrogated…”
Get full text
Journal Article -
2
Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma
Published in Haematologica (Roma) (07-11-2024)“…Not available.Not available…”
Get full text
Journal Article -
3
The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
Published in Frontiers in oncology (18-05-2022)“…Measurable residual disease (MRD) is being recognised as an optimal method for assessing depth of response, identifying higher risk of relapse, and guiding…”
Get full text
Journal Article -
4
Evaluation of EuroFlow minimal residual disease measurement and donor chimerism monitoring following tandem auto-allogeneic transplantation for multiple myeloma
Published in Bone marrow transplantation (Basingstoke) (01-05-2021)“…Prognostic factors for multiple myeloma (MM) after allogeneic haemopoietic stem cell transplantation (alloHSCT) are poorly characterised. Two potential factors…”
Get full text
Journal Article -
5
Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort
Published in PloS one (04-08-2011)“…Asplenic patients have a lifelong risk of overwhelming post-splenectomy infection and have been reported to have low numbers of peripheral blood IgM memory B…”
Get full text
Journal Article -
6
A Reverse-Genetics Mutational Analysis of the Barley HvDWARF Gene Results in Identification of a Series of Alleles and Mutants with Short Stature of Various Degree and Disturbance in BR Biosynthesis Allowing a New Insight into the Process
Published in International journal of molecular sciences (22-04-2016)“…Brassinosteroids (BRs) are plant steroid hormones, regulating a broad range of physiological processes. The largest amount of data related with BR biosynthesis…”
Get full text
Journal Article -
7
A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia
Published in Haematologica (Roma) (01-02-2015)Get full text
Journal Article -
8
Cloning and Functional Analysis of Rat Tweety-Homolog 1 Gene Promoter
Published in Neurochemical research (01-09-2021)“…Tweety-homolog 1 protein ( Ttyh1 ) is abundantly expressed in neurons in the healthy brain, and its expression is induced under pathological conditions. In…”
Get full text
Journal Article -
9
-
10
Evaluation of Easym, a Clonotypic Mass Spectrometry Assay, and Euroflow Minimal Residual Disease Assessment in Multiple Myeloma
Published in Blood (02-11-2023)“…Introduction: Minimal residual disease (MRD) negativity is increasingly recognised as the optimal measure of therapeutic response for multiple myeloma (MM)…”
Get full text
Journal Article -
11
Laboratory validation and clinical utility of next-generation sequencing-based IGH/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology
Published in Pathology (01-12-2024)“…Measurable residual disease (MRD) testing is an essential aspect of disease prognostication in acute lymphoblastic leukaemia (ALL) and informs clinical…”
Get full text
Journal Article -
12
T-cell clonality assessment by flow cytometry using anti-TCR-Cβ-1: A tertiary hospital experience
Published in Pathology (01-03-2022)Get full text
Journal Article -
13
Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia
Published in Cytometry. Part B, Clinical cytometry (01-03-2022)“…Background Measurable residual disease (MRD) monitoring in acute lymphoblastic leukemia (ALL) is an important predictive factor for patient outcome and…”
Get full text
Journal Article -
14
Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy - Final Analysis from the Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial
Published in Blood (23-11-2021)“…BACKGROUND Survival rates in multiple myeloma (MM) have significantly improved in recent decades with the advent of high-dose chemotherapy conditioned…”
Get full text
Journal Article -
15
Ttyh1 Protein is Expressed in Glia In Vitro and Shows Elevated Expression in Activated Astrocytes Following Status Epilepticus
Published in Neurochemical research (01-12-2014)“…In a previous study, we showed that Ttyh1 protein is expressed in neurons in vitro and in vivo in the form of punctuate structures, which are localized to…”
Get full text
Journal Article -
16
HorTILLUS—A Rich and Renewable Source of Induced Mutations for Forward/Reverse Genetics and Pre-breeding Programs in Barley (Hordeum vulgare L.)
Published in Frontiers in plant science (21-02-2018)“…TILLING (Targeting Induced Local Lesions IN Genomes) is a strategy used for functional analysis of genes that combines the classical mutagenesis and a rapid,…”
Get full text
Journal Article -
17
E-Learning-Modul "Planung experimenteller Untersuchungen": Entwicklung und Wirkungskontrolle
Published in Zeitschrift für Hochschulentwicklung (01-05-2011)“…Langjährige Erfahrungen und Prüfungsergebnisse zeigen, dass die Aneignung und die Anwendung methodischen Wissens zur Versuchsplanung von vielen Studierenden…”
Get full text
Journal Article -
18
A Longitudinal Evaluation of Euroflow and Combined Quantitative Immunoprecipitation (QIP) and Free Light Chain (FLC) Mass Spectometry (MS) in Functional High Risk Multiple Myeloma
Published in Blood (13-11-2019)“…Introduction: The achievement of minimal residual disease (MRD) negativity is being increasingly recognised as the optimal measure of therapeutic response for…”
Get full text
Journal Article -
19
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis
Published in Cytometry. Part B, Clinical cytometry (01-03-2022)“…Background Multiple myeloma (MM) measurable residual disease (MRD) evaluated by flow cytometry is a surrogate for progression‐free and overall survival in…”
Get full text
Journal Article -
20
Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy
Published in Blood (29-11-2018)“…Background Data from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (MRDR) shows that 85% of newly diagnosed multiple myeloma…”
Get full text
Journal Article